Redeye provides a research update following Hoylu’s Q4 2022 report. The ARR amounted to SEK51.9m and was already known thanks to its monthly ARR reporting, while the cost side came in somewhat lower than anticipated when adjusting for one-offs. Overall, we make minor forecast adjustments while the fair value range is kept intact.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/